BMS-986484
- Generic Name
- BMS-986484
A Study of BMS-986484 Alone and Combination Therapy in Participants With Advanced Solid Tumors
- First Posted Date
- 2024-08-09
- Last Posted Date
- 2025-03-17
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 134
- Registration Number
- NCT06544655
- Locations
- 🇦🇺
St Vincent's Hospital, Darlinghurst, New South Wales, Australia
🇨🇦Princess Margaret Cancer Centre, Toronto, Ontario, Canada
🇺🇸Local Institution - 0003, Tucson, Arizona, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath